|
 |
| 8 January 2008 Lifeline Scientific, Inc. - 7 January 2008 Lifeline Scientific announces successful completion of IPO Addressing the global problem of human donor organ shortage Lifeline Scientific, a medical technology company primarily focused on commercialising its LifePort® Kidney Transporter, a product designed to address the global challenge of human donor organ shortages, announces the successful completion of its flotation on the AIM Market of the London Stock Exchange. The Company raised a total of £5.4 million from the placing of new common shares with institutional and other investors at a price of 150p per share. Downloads  20080108-ORS-IPO_Completion.pdf - (pdf)
 back
|
